EXTON, Pa. and COURBEVOIE, France, April 1
(Bernama-GLOBE NEWSWIRE) -- Morphotek®, Inc., a subsidiary of Eisai Inc., and AREVA Med, the AREVA
Group medical subsidiary developing innovative therapies to fight cancer,
announced today that they have entered into a collaborative project to assess
the potential of a novel alpha radio-immunotherapy treatment in the fight
against cancer.
No comments:
Post a Comment